All Pharma News
Recursion acquires two AI-based drug discovery companies in $87.5M deal

Recursion acquires two AI-based drug discovery companies in $87.5M deal
Katherine Lewin ENDPTS
08 May 2023
Share Share
Corrected: Zevra CEO hits the exit as minority shareholder`s nominees

Corrected: Zevra CEO hits the exit as minority shareholder`s nominees
Tyler Patchen ENDPTS
08 May 2023
Share Share
KemPharm Announces Corporate Name Change to Zevra Therapeutics

KemPharm Announces Corporate Name Change to Zevra Therapeutics
GLOBENEWSWIRE
22 Feb 2023
Share Share
KemPharm Enhances Senior Management Team

KemPharm Enhances Senior Management Team
GLOBENEWSWIRE
31 Jan 2023
Share Share
KemPharm Issues Letter to Shareholders

KemPharm Issues Letter to Shareholders
GLOBENEWSWIRE
24 Jan 2023
Share Share
KemPharm Partners with Hypersomnia Foundation for Sleep Disorder Research

KemPharm Partners with Hypersomnia Foundation for Sleep Disorder Research
GLOBENEWSWIRE
18 Jan 2023
Share Share
KemPharm Announces Promotion of Sven Guenther to CSO and Christal Mickle to CPDO

KemPharm Announces Promotion of Sven Guenther to CSO and Christal Mickle to CPDO
GLOBENEWSWIRE
11 Jan 2023
Share Share
KemPharm Announces Leadership Changes to Support its Rare Disease Company

KemPharm Announces Leadership Changes to Support its Rare Disease Company
GLOBENEWSWIRE
09 Jan 2023
Share Share
KemPharm Announces Initiation of Phase 2 Clinical Trial Investigating KP1077

KemPharm Announces Initiation of Phase 2 Clinical Trial Investigating KP1077
GLOBENEWSWIRE
21 Dec 2022
Share Share
KemPharm Announces Appointment of Christopher Posner as New Independent Director

KemPharm Announces Appointment of Christopher Posner as New Independent Director
GLOBENEWSWIRE
29 Nov 2022
Share Share